These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17163249)

  • 1. Cradle-to-Grave Emission Reduction for Easyhaler Dry Powder Inhaler Product Portfolio.
    Inget M; Hisinger-Mölkänen H; Howard M; Lähelmä S; Paronen N
    Pulm Ther; 2023 Dec; 9(4):527-533. PubMed ID: 37749379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching to the Dry-Powder Inhaler Easyhaler
    Lavorini F; Chudek J; Gálffy G; Pallarés-Sanmartin A; Pelkonen AS; Rytilä P; Syk J; Szilasi M; Tamási L; Xanthopoulos A; Haahtela T
    Pulm Ther; 2021 Dec; 7(2):409-427. PubMed ID: 34581994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Today's improvement in asthma treatment: role of MART and Easyhaler.
    Di Marco F
    Multidiscip Respir Med; 2020 Jan; 15(1):649. PubMed ID: 32983452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime.
    Turpeinen A; Eriksson P; Happonen A; Husman-Piirainen J; Haikarainen J
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):189-196. PubMed ID: 32960127
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
    Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
    Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easyhaler
    Lavorini F
    Drugs Context; 2019; 8():212596. PubMed ID: 31210773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose uniformity of budesonide Easyhaler® under simulated real-life conditions and with low inspiration flow rates.
    Haikarainen J; Rytilä P; Roos S; Metsärinne S; Happonen A
    Chron Respir Dis; 2018 Aug; 15(3):265-271. PubMed ID: 29216744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.
    Pirożyński M; Hantulik P; Almgren-Rachtan A; Chudek J
    Adv Ther; 2017 Dec; 34(12):2648-2660. PubMed ID: 29119403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
    Malmberg LP; Everard ML; Haikarainen J; Lähelmä S
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients.
    Price D; Thomas V; von Ziegenweidt J; Gould S; Hutton C; King C
    J Asthma Allergy; 2014; 7():31-51. PubMed ID: 24748807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
    Gálffy G; Mezei G; Németh G; Tamási L; Müller V; Selroos O; Orosz M
    Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice.
    Azouz W; Chrystyn H
    Prim Care Respir J; 2012 Jun; 21(2):208-13. PubMed ID: 22336894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closer to an 'ideal inhaler' with the Easyhaler: an innovative dry powder inhaler.
    Chrystyn H
    Clin Drug Investig; 2006; 26(4):175-83. PubMed ID: 17163249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of dry powder inhaler dose delivery characteristics using a power criterion.
    Dunbar CA; Morgan B; Van Oort M ; Hickey AJ
    PDA J Pharm Sci Technol; 2000; 54(6):478-84. PubMed ID: 11107840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of capsule dosing techniques for use in dry powder inhalers.
    Edwards D
    Ther Deliv; 2010 Jul; 1(1):195-201. PubMed ID: 22816126
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.